CGON: CG Oncology Therapeutics Narx/daromad multiplikatori

CG Oncology Inc (CGON) kompaniyasining korporativ logotipi

Daromadni baholash ko'rsatkichi CG Oncology, Inc. (CGON) dinamikasini aks ettiradi, bunda 1225.50 ushbu ko'rsatkichning joriy qiymatidir. Biznes qat'iy FDA nazorati va ulkan R&D xarajatlariga duch kelmoqda. Shu bilan birga, noyob onkolitik viruslar qovuq o'smalarini samarali yo'q qilish imkonini beradi. Ommaviy savdolarga o'tish operatsion leverajni yaratadi, bu esa tarixiy ishlanmalar xarajatlarini sezilarli darajada optimallashtiradi.

CGON: CG Oncology Corp Narxning daromadga nisbati 14.11.2024 - 17.11.2026

cgoncology.com (CGON) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning fundamental tahlili:CGON - CG Oncology Inc
CG Oncology, Inc. tomonidan chiqariladigan mahsulotlar

CG Oncology, Inc. (CGON) investorlari biznesning bozor qiymatini uning pul oqimini yaratish qobiliyatiga nisbatan tushunishlari kerak. Ushbu ko'rsatkich emitentning umumiy bozor kapitalizatsiyasining yillik savdoga nisbati sifatida hisoblanadi va savdo-narx nisbatini tahlil qilish saraton davolashga bo'lgan noelastik talab fonida onkolitik terapiyalarning noyoblik premiumini baholash imkonini beradi.

CG Oncology, Inc. raqobatchilari

ONC - Sotuvga nisbatan narx|P/S multiplikatori HALO (Halozyme Therapeutics, Inc.)|Revolution Medicines (RVMD) - Sotuvga nisbatan narx|ascentage.com - P/S multiplikatori|Sotuvga nisbatan narx UroGen Pharma Ltd.|BCAX: P/S multiplikatori|PSNL - Narx/daromad koeffitsiyenti|ERAS (Erasca Oncology) - P/S multiplikatori|P/S multiplikatori Delcath Systems, Inc.|Narxning daromadga nisbati ymabs.com (YMAB)|Narxning daromadga nisbati AURA (Aura Biosciences, Inc.)|Candel Therapeutics - Kapitalizatsiyaning daromadga nisbati|Accuray Inc. (ARAY) - Sotuvga nisbatan narx|SELLAS Life Sciences Group, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACTU (Actuate Therapeutics, Inc.)|Citius Oncology (CTOR) - Narxning daromadga nisbati|HURA - Narx/daromad koeffitsiyenti|TARA (Protara Therapeutics, Inc.) - P/S multiplikatori|P/S multiplikatori Fate Therapeutics Inc|P/S multiplikatori WHWK|P/S multiplikatori TScan Therapeutics Inc (TCRX)|Narxning daromadga nisbati championsoncology.com CSBR|XBIT - Kapitalizatsiyaning daromadga nisbati|CVM - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati OSTX (OS Therapies)|RADX: P/S multiplikatori|Artiva Biotherapeutics Inc. - Bozor kapitallashuvining daromadga nisbati|ANL (Adlai Nortye) - P/S multiplikatori|P/S multiplikatori verupharma.com|Kapitalizatsiyaning daromadga nisbati TPST (tempesttx.com)|Kapitalizatsiyaning daromadga nisbati Xilio Therapeutics Inc XLO|P/S multiplikatori RENB (Enochian BioSciences)|Mural Bio - Narxning daromadga nisbati|KAPA - Narxning daromadga nisbati|OnKure Therapeutics (OKUR) - Kapitalizatsiyaning daromadga nisbati|GDTC: P/S multiplikatori|Sotuvga nisbatan narx Curis Corp (CRIS)|APLM (apollomicsinc.com) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Tharimmune Corp (THAR)|P/S multiplikatori ADVB|GNPX - Sotuvga nisbatan narx|Narxning daromadga nisbati calidibio.com CLDI|SBFM - Kapitalizatsiyaning daromadga nisbati|XBIO - Narxning daromadga nisbati|SLRX: Narxning daromadga nisbati|Purple Biotech (PPBT) - Narxning daromadga nisbati|AON - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati BGNE|P/S multiplikatori Checkpoint Therapeutics Inc.|P/S multiplikatori ELEV|Kapitalizatsiyaning daromadga nisbati iCAD ICAD|P/S multiplikatori IKNA (Ikena Oncology, Inc.)|Bozor kapitallashuvining daromadga nisbati NTBL|Viracta Therapeutics, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati MOR (MorphoSys Inc)|NAYA (NAYA Biosciences Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Ascentage Pharma Group Ltd